Loading insider details...
Latest Form 4 (Oct 19, 2026): Grant/Award of 29 VRTX shares, $15.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 29 | $15.0K |
| Jul 17, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 32 | $15.0K |
| May 5, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 472 | n/a |
| Apr 17, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 34 | $15.0K |
| May 5, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 398 | n/a |
| May 3, 2024 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 3,142 | n/a |
| Mar 25, 2024 | EXELIXIS, INC. (EXEL) | Exercise/Conversion | 23,491 | $459.7K |
| Jun 3, 2023 | EXELIXIS, INC. (EXEL) | Grant/Award | 44,087 | n/a |
| May 3, 2023 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 584 | n/a |
| Feb 24, 2023 | EXELIXIS, INC. (EXEL) | Exercise/Conversion | 40,000 | $252.0K |